Ronald L. Hanson, Brian L. Davis, Yijun Chen, Steven L. Goldberg, William L. Parker, Thomas P. Tully, and Ramesh N. Patel. Process Research & Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, NJ 08903
Chiral amines are required for synthesis of many pharmaceutically interesting compounds. Screening was carried out to identify strains useful for preparation of (R)-1-cyclopropylethylamine and (R)-sec-butylamine by resolution of the racemic amines with an S-specific transaminase. Several Bacillus megaterium strains from our culture collection as well as several soil isolates were found to have the desired activity for resolution of the racemic amines to give the R-enantiomers. Using an extract of the best strain, Bacillus megaterium SC6394, the reaction was shown to be a transamination requiring pyruvate as amino acceptor and pyridoxal phosphate as a cofactor. Initial batches of both amines were produced using whole cells of Bacillus megaterium SC6394. The transaminase was purified to homogeneity and the gene was cloned and expressed in E. coli SC16578. In contrast to the original B. megaterium process, pH control and aeration were not required for resolution of sec-butylamine and an excess of pyruvate was not consumed by the recombinant cells. The resolution of sec-butylamine (0.68 M) using whole cells of E. coli SC16578 was scaled up to give (R)-sec-butylamine·½ H2SO4 in 46.6% isolated yield with 99.2% ee. An alternative isolation procedure was also used to isolate (R)-sec-butylamine as the free base.